{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:52:28Z","timestamp":1781643148986,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Liaoning Province Science and Technology Joint Plan","award":["2023JH2\/101700154"],"award-info":[{"award-number":["2023JH2\/101700154"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabolic alterations are key factors driving the development of breast cancer. Among them, metabolic reprogramming is an important biological hallmark of breast cancer. It is crucial to gain in-depth understanding of the relevant mechanisms and find effective treatment strategies. Isoimperatorin (ISO), a natural furanocoumarin, exhibits various pharmacological effects such as anti-inflammatory and antiviral activities. However, the impact of ISO on the growth of breast cancer cells and its underlying mechanisms remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Cell culture, transfection, and animal experiments were employed. CCK\u2009-8, colony formation, and flow cytometry were used to detect cell proliferation, apoptosis, and ROS levels. miRNA-Seq, qRT-PCR, and Western Blotting were applied to analyze gene and protein expression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>ISO inhibited breast cancer cell proliferation, induced apoptosis and ROS accumulation, and suppressed the Warburg effect. ISO upregulated miR-\u2009874-3p, which directly targeted the 3\u2032-UTR of POU2F1, inhibiting the transcriptional activation of key glycolytic genes. Blocking this axis reversed ISO\u2019s tumor-suppressive effects in vitro and in vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study first reveals a novel mechanism by which ISO regulates breast cancer metabolism and apoptosis via the miR-874-3p\/POU2F1 axis, highlighting ISO\u2019s potential as a dual metabolic-redox intervention agent and providing a new combined therapeutic target for breast cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40659-026-00678-x","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T12:16:34Z","timestamp":1773317794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Isoimperatorin suppresses triple-negative breast cancer by modulating miR-874-3p\/POU2F1 axis: a new avenue for metabolic and redox intervention"],"prefix":"10.1186","volume":"59","author":[{"given":"Shuo","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexuan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruishan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"issue":"Suppl 2 Suppl 2","key":"678_CR1","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.3816\/CBC.2009.s.008","volume":"9","author":"CK Anders","year":"2009","unstructured":"Anders CK, Carey LA. Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer. Clin Breast Cancer. 2009;9(Suppl 2):S73\u201381. https:\/\/doi.org\/10.3816\/CBC.2009.s.008.","journal-title":"Clin Breast Cancer"},{"key":"678_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"678_CR3","doi-asserted-by":"publisher","first-page":"926","DOI":"10.3390\/cancers13040926","volume":"13","author":"R Kim","year":"2021","unstructured":"Kim R, Kin T. Clinical perspectives in addressing unsolved issues in (Neo)Adjuvant therapy for primary breast cancer. Cancers (Basel). 2021;13:926. https:\/\/doi.org\/10.3390\/cancers13040926.","journal-title":"Cancers (Basel)"},{"key":"678_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41419-019-2213-x","volume":"11","author":"W Ji","year":"2020","unstructured":"Ji W, Diao Y-L, Qiu Y-R, Ge J, Cao X-C, Yu Y. LINC00665 promotes breast cancer progression through regulation of the miR-379-5p\/LIN28B axis. Cell Death Dis. 2020;11:16. https:\/\/doi.org\/10.1038\/s41419-019-2213-x.","journal-title":"Cell Death Dis"},{"key":"678_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12943-024-02165-x","volume":"23","author":"S Liu","year":"2024","unstructured":"Liu S, Zhang X, Wang W, Li X, Sun X, Zhao Y, et al. Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer. Mol Cancer. 2024;23:261. https:\/\/doi.org\/10.1186\/s12943-024-02165-x.","journal-title":"Mol Cancer"},{"key":"678_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2015.12.006","author":"P Nn","year":"2016","unstructured":"Nn P, Cb T. The emerging hallmarks of cancer metabolism. Cell Metabol. 2016. https:\/\/doi.org\/10.1016\/j.cmet.2015.12.006. 23.","journal-title":"Cell Metabol"},{"key":"678_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2049-3002-2-1","volume":"2","author":"P Lee","year":"2014","unstructured":"Lee P, Vousden KH, Cheung EC. TIGAR, TIGAR, burning bright. Cancer Metab. 2014;2:1. https:\/\/doi.org\/10.1186\/2049-3002-2-1.","journal-title":"Cancer Metab"},{"key":"678_CR8","doi-asserted-by":"publisher","first-page":"36114","DOI":"10.1038\/srep36114","volume":"6","author":"C Gao","year":"2016","unstructured":"Gao C, Yan X, Wang B, Yu L, Han J, Li D, et al. Jolkinolide B induces apoptosis and inhibits tumor growth in mouse melanoma B16F10 cells by altering glycolysis. Sci Rep. 2016;6:36114. https:\/\/doi.org\/10.1038\/srep36114.","journal-title":"Sci Rep"},{"key":"678_CR9","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.3390\/cancers11101496","volume":"11","author":"R Wei","year":"2019","unstructured":"Wei R, Hackman RM, Wang Y, Mackenzie GG. Targeting glycolysis with epigallocatechin-3-Gallate enhances the efficacy of chemotherapeutics in pancreatic cancer cells and xenografts. Cancers (Basel). 2019;11:1496. https:\/\/doi.org\/10.3390\/cancers11101496.","journal-title":"Cancers (Basel)"},{"key":"678_CR10","doi-asserted-by":"publisher","first-page":"6203","DOI":"10.3390\/cancers14246203","volume":"14","author":"ST Asma","year":"2022","unstructured":"Asma ST, Acaroz U, Imre K, Morar A, Shah SRA, Hussain SZ, et al. Natural products\/bioactive compounds as a source of anticancer drugs. Cancers (Basel). 2022;14:6203. https:\/\/doi.org\/10.3390\/cancers14246203.","journal-title":"Cancers (Basel)"},{"key":"678_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.intimp.2017.05.012","volume":"49","author":"CUB Wijerathne","year":"2017","unstructured":"Wijerathne CUB, Seo C-S, Song J-W, Park H-S, Moon O-S, Won Y-S, et al. Isoimperatorin attenuates airway inflammation and mucus hypersecretion in an ovalbumin-induced murine model of asthma. Int Immunopharmacol. 2017;49:67\u201376. https:\/\/doi.org\/10.1016\/j.intimp.2017.05.012.","journal-title":"Int Immunopharmacol"},{"key":"678_CR12","doi-asserted-by":"publisher","first-page":"657826","DOI":"10.3389\/fphar.2021.657826","volume":"12","author":"Y Lai","year":"2021","unstructured":"Lai Y, Han T, Zhan S, Jiang Y, Liu X, Li G. Antiviral activity of isoimperatorin against influenza A virus in vitro and its Inhibition of neuraminidase. Front Pharmacol. 2021;12:657826. https:\/\/doi.org\/10.3389\/fphar.2021.657826.","journal-title":"Front Pharmacol"},{"key":"678_CR13","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.jep.2010.10.004","volume":"133","author":"L Moon","year":"2011","unstructured":"Moon L, Ha YM, Jang HJ, Kim HS, Jun MS, Kim YM, et al. Isoimperatorin, cimiside E and 23-O-acetylshengmanol-3-xyloside from cimicifugae rhizome inhibit TNF-\u03b1-induced VCAM-1 expression in human endothelial cells: involvement of PPAR-\u03b3 upregulation and PI3K, ERK1\/2, and PKC signal pathways. J Ethnopharmacol. 2011;133:336\u201344. https:\/\/doi.org\/10.1016\/j.jep.2010.10.004.","journal-title":"J Ethnopharmacol"},{"key":"678_CR14","doi-asserted-by":"publisher","first-page":"110433","DOI":"10.1016\/j.cellsig.2022.110433","volume":"99","author":"NY Kim","year":"2022","unstructured":"Kim NY, Jung YY, Yang MH, Um J-Y, Sethi G, Ahn KS. Isoimperatorin down-regulates epithelial mesenchymal transition through modulating NF-\u03baB signaling and CXCR4 expression in colorectal and hepatocellular carcinoma cells. Cell Signal. 2022;99:110433. https:\/\/doi.org\/10.1016\/j.cellsig.2022.110433.","journal-title":"Cell Signal"},{"key":"678_CR15","doi-asserted-by":"publisher","first-page":"6512","DOI":"10.3390\/molecules27196512","volume":"27","author":"T Kim","year":"2022","unstructured":"Kim T, Hyun C-G. Imperatorin positively regulates melanogenesis through signaling pathways involving PKA\/CREB, ERK, AKT, and GSK3\u03b2\/\u03b2-Catenin. Molecules. 2022;27:6512. https:\/\/doi.org\/10.3390\/molecules27196512.","journal-title":"Molecules"},{"key":"678_CR16","doi-asserted-by":"publisher","first-page":"7993","DOI":"10.3892\/ol.2018.8303","volume":"15","author":"H-B Yang","year":"2018","unstructured":"Yang H-B, Gao H-R, Ren Y-J, Fang F-X, Tian H-T, Gao Z-J, et al. Effects of isoimperatorin on proliferation and apoptosis of human gastric carcinoma cells. Oncol Lett. 2018;15:7993\u20138. https:\/\/doi.org\/10.3892\/ol.2018.8303.","journal-title":"Oncol Lett"},{"key":"678_CR17","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3892\/ol.2016.5387","volume":"13","author":"K Tong","year":"2017","unstructured":"Tong K, Xin C, Chen W. Isoimperatorin induces apoptosis of the SGC-7901 human gastric cancer cell line via the mitochondria-mediated pathway. Oncol Lett. 2017;13:518\u201324. https:\/\/doi.org\/10.3892\/ol.2016.5387.","journal-title":"Oncol Lett"},{"key":"678_CR18","doi-asserted-by":"publisher","first-page":"1296588","DOI":"10.3389\/fphar.2024.1296588","volume":"15","author":"H-E Qin","year":"2024","unstructured":"Qin H-E, Peng L, Xu Y-C, Zhang Z-X, Tian R-F, Wan Z-X, et al. GuiErBai: a potent inhibitor, exhibiting broadly antitumor effect against cervical cancer in vitro and in vivo. Front Pharmacol. 2024;15:1296588. https:\/\/doi.org\/10.3389\/fphar.2024.1296588.","journal-title":"Front Pharmacol"},{"key":"678_CR19","doi-asserted-by":"publisher","first-page":"15743","DOI":"10.1038\/s41598-019-52162-0","volume":"9","author":"R Acharya","year":"2019","unstructured":"Acharya R, Chacko S, Bose P, Lapenna A, Pattanayak SP. Structure based multitargeted molecular Docking analysis of selected furanocoumarins against breast cancer. Sci Rep. 2019;9:15743. https:\/\/doi.org\/10.1038\/s41598-019-52162-0.","journal-title":"Sci Rep"},{"key":"678_CR20","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis C, Shah SP, Chin S-F, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcriptomic architecture of 2000 breast tumours reveals novel subgroups. Nature. 2012;486:346\u201352. https:\/\/doi.org\/10.1038\/nature10983.","journal-title":"Nature"},{"key":"678_CR21","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.3390\/life12091435","volume":"12","author":"AG Stepchenko","year":"2022","unstructured":"Stepchenko AG, Bulavkina EV, Portseva TN, Georgieva SG, Pankratova EV. Suppression of OCT-1 in metastatic breast cancer cells reduces tumor metastatic potential, hypoxia resistance, and drug resistance. Life (Basel). 2022;12:1435. https:\/\/doi.org\/10.3390\/life12091435.","journal-title":"Life (Basel)"},{"key":"678_CR22","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41388-021-02148-y","volume":"41","author":"J Lin","year":"2022","unstructured":"Lin J, Xia L, Oyang L, Liang J, Tan S, Wu N, et al. The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity. Oncogene. 2022;41:1024\u201339. https:\/\/doi.org\/10.1038\/s41388-021-02148-y.","journal-title":"Oncogene"},{"key":"678_CR23","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1093\/bjr\/tqaf148","volume":"98","author":"MMA Elbasheer","year":"2025","unstructured":"Elbasheer MMA, Dodwell D, Gathani T. Understanding global variation in breast cancer mortality. Br J Radiol. 2025;98:1369\u201372. https:\/\/doi.org\/10.1093\/bjr\/tqaf148.","journal-title":"Br J Radiol"},{"key":"678_CR24","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1080\/09168451.2020.1751581","volume":"84","author":"B Zeng","year":"2020","unstructured":"Zeng B, Li K, Yang Z, Wang H, Wang C, Huang P, et al. Isoimperatorin (ISO) reduces melanin content in keratinocytes via miR-3619\/CSTB and miR-3619\/CSTD axes. Biosci Biotechnol Biochem. 2020;84:1436\u201343. https:\/\/doi.org\/10.1080\/09168451.2020.1751581.","journal-title":"Biosci Biotechnol Biochem"},{"key":"678_CR25","doi-asserted-by":"publisher","first-page":"449","DOI":"10.4168\/aair.2015.7.5.449","volume":"7","author":"G Wu","year":"2015","unstructured":"Wu G, Yang G, Zhang R, Xu G, Zhang L, Wen W, et al. Altered MicroRNA expression profiles of extracellular vesicles in nasal mucus from patients with allergic rhinitis. Allergy Asthma Immunol Res. 2015;7:449\u201357. https:\/\/doi.org\/10.4168\/aair.2015.7.5.449.","journal-title":"Allergy Asthma Immunol Res"},{"key":"678_CR26","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.1074\/jbc.M115.687152","volume":"291","author":"P Kushwaha","year":"2016","unstructured":"Kushwaha P, Khedgikar V, Sharma D, Yuen T, Gautam J, Ahmad N, et al. MicroRNA 874-3p exerts skeletal anabolic effects epigenetically during weaning by suppressing Hdac1 expression. J Biol Chem. 2016;291:3959\u201366. https:\/\/doi.org\/10.1074\/jbc.M115.687152.","journal-title":"J Biol Chem"},{"key":"678_CR27","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00535-013-0851-9","volume":"49","author":"B Jiang","year":"2014","unstructured":"Jiang B, Li Z, Zhang W, Wang H, Zhi X, Feng J, et al. miR-874 inhibits cell proliferation, migration and invasion through targeting aquaporin-3 in gastric cancer. J Gastroenterol. 2014;49:1011\u201325. https:\/\/doi.org\/10.1007\/s00535-013-0851-9.","journal-title":"J Gastroenterol"},{"key":"678_CR28","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s13046-022-02415-0","volume":"41","author":"S-D Luo","year":"2022","unstructured":"Luo S-D, Tsai H-T, Hwang C-F, Chiu T-J, Li S-H, Hsu Y-L, et al. Aberrant miR-874-3p\/leptin\/EGFR\/c-Myc signaling contributes to nasopharyngeal carcinoma pathogenesis. J Exp Clin Cancer Res. 2022;41:215. https:\/\/doi.org\/10.1186\/s13046-022-02415-0.","journal-title":"J Exp Clin Cancer Res"},{"key":"678_CR29","doi-asserted-by":"publisher","first-page":"705","DOI":"10.18632\/aging.204474","volume":"15","author":"H Yang","year":"2023","unstructured":"Yang H, Wang Z, Hu S, Chen L, Li W, Yang Z. miRNA-874-3p inhibits the migration, invasion and proliferation of breast cancer cells by targeting VDAC1. Aging. 2023;15:705\u201317. https:\/\/doi.org\/10.18632\/aging.204474.","journal-title":"Aging"},{"key":"678_CR30","doi-asserted-by":"publisher","first-page":"291","DOI":"10.32604\/or.2022.025172","volume":"29","author":"YI Dong","year":"2021","unstructured":"Dong YI, Zhang L, Guan X, Liu T, Zhou L. Long noncoding RNA LINC02568 sequesters microRNA-874-3p to facilitate malignancy in breast cancer cells via Cyclin E1 overexpression. Oncol Res. 2021;29:291\u2013303. https:\/\/doi.org\/10.32604\/or.2022.025172.","journal-title":"Oncol Res"},{"key":"678_CR31","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12967-022-03391-x","volume":"20","author":"J Wang","year":"2022","unstructured":"Wang J, Hou F, Tang L, Xiao K, Yang T, Wang Z, et al. The interaction between long non-coding RNA LINC01564 and POU2F1 promotes the proliferation and metastasis of gastric cancer. J Transl Med. 2022;20:220. https:\/\/doi.org\/10.1186\/s12967-022-03391-x.","journal-title":"J Transl Med"},{"key":"678_CR32","doi-asserted-by":"publisher","first-page":"11505","DOI":"10.3390\/ijms222111505","volume":"22","author":"T Ogura","year":"2021","unstructured":"Ogura T, Azuma K, Sato J, Kinowaki K, Takayama K-I, Takeiwa T, et al. OCT1 is a poor prognostic factor for breast cancer patients and promotes cell proliferation via inducing NCAPH. Int J Mol Sci. 2021;22:11505. https:\/\/doi.org\/10.3390\/ijms222111505.","journal-title":"Int J Mol Sci"},{"key":"678_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1136\/gutjnl-2013-306584","volume":"64","author":"J Qian","year":"2015","unstructured":"Qian J, Kong X, Deng N, Tan P, Chen H, Wang J, et al. OCT1 is a determinant of synbindin-related ERK signalling with independent prognostic significance in gastric cancer. Gut. 2015;64:37\u201348. https:\/\/doi.org\/10.1136\/gutjnl-2013-306584.","journal-title":"Gut"},{"key":"678_CR34","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1097\/CM9.0000000000003181","volume":"138","author":"Y Xiao","year":"2025","unstructured":"Xiao Y, Yang P, Xiao W, Yu Z, Li J, Li X, et al. POU2F1 inhibits miR-29b1\/a cluster-mediated suppression of PIK3R1 and PIK3R3 expression to regulate gastric cancer cell invasion and migration. Chin Med J (Engl). 2025;138:838\u201350. https:\/\/doi.org\/10.1097\/CM9.0000000000003181.","journal-title":"Chin Med J (Engl)"},{"key":"678_CR35","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/2211-5463.12628","volume":"9","author":"A Korga","year":"2019","unstructured":"Korga A, Ostrowska M, Iwan M, Herbet M, Dudka J. Inhibition of glycolysis disrupts cellular antioxidant defense and sensitizes HepG2 cells to doxorubicin treatment. FEBS Open Bio. 2019;9:959\u201372. https:\/\/doi.org\/10.1002\/2211-5463.12628.","journal-title":"FEBS Open Bio"},{"key":"678_CR36","doi-asserted-by":"publisher","first-page":"2251234","DOI":"10.1080\/13510002.2023.2251234","volume":"28","author":"K-H Xue","year":"2023","unstructured":"Xue K-H, Jiang Y-F, Bai J-Y, Zhang D-Z, Chen Y-H, Ma J-B, et al. Melatonin suppresses Akt\/mTOR\/S6K activity, induces cell apoptosis, and synergistically inhibits cell growth with Sunitinib in renal carcinoma cells via reversing Warburg effect. Redox Rep. 2023;28:2251234. https:\/\/doi.org\/10.1080\/13510002.2023.2251234.","journal-title":"Redox Rep"},{"key":"678_CR37","doi-asserted-by":"publisher","first-page":"21940","DOI":"10.1038\/s41598-020-79019-1","volume":"10","author":"L Jin","year":"2020","unstructured":"Jin L, Kim E-Y, Chung T-W, Han CW, Park SY, Han JH, et al. Hemistepsin A suppresses colorectal cancer growth through inhibiting pyruvate dehydrogenase kinase activity. Sci Rep. 2020;10:21940. https:\/\/doi.org\/10.1038\/s41598-020-79019-1.","journal-title":"Sci Rep"},{"key":"678_CR38","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-25-1282","author":"B Li","year":"2025","unstructured":"Li B, Li H, Li Y, Chen Z, Zou D, He C, et al. Genetic control of tRNA-derived fragments contributes to cancer risk. Cancer Res. 2025. https:\/\/doi.org\/10.1158\/0008-5472.CAN-25-1282.","journal-title":"Cancer Res"}],"container-title":["Biological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40659-026-00678-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-026-00678-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-026-00678-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:57:18Z","timestamp":1781639838000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40659-026-00678-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["678"],"URL":"https:\/\/doi.org\/10.1186\/s40659-026-00678-x","relation":{},"ISSN":["0717-6287"],"issn-type":[{"value":"0717-6287","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was approved by the Ethics Committee of China Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}